SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emcure Pharmaceuticals gets EIR for Pune manufacturing facility

21 Apr 2025 Evaluate

Emcure Pharmaceuticals has received Establishment Inspection Report (EIR) for its manufacturing facility located at Pune. Further, United States Food & Drug Administration (USFDA) has classified the inspection of the said facility as ‘Voluntary Action Indicated’ (VAI).

Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.  

Emcure Pharma Share Price

1695.60 54.00 (3.29%)
11-May-2026 11:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1877.45
Dr. Reddys Lab 1290.00
Cipla 1332.00
Zydus Lifesciences 945.20
Lupin 2256.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×